ASPREE Completion Project

ASPREE竣工项目

• 批准号: nhmrc : GNT1127060
• 负责人: A/Pr Robyn Woods
• 金额: $ 479.67万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/aspree-completion-project/1347592
• 关键词: ASPREE; Completion; Project

ASPREE is the largest clinical trial ever conducted in Australia and will determine whether daily low dose aspirin prevents disease in healthy older people. The study was well-funded initially but will require additional support to complete the vital final stage of data collection and analysis. This will enable the study to answer important questions about the benefits and risks of aspirin in this age group and its effect on disability free survival.

ASPREE是澳大利亚有史以来规模最大的临床试验，将确定每日低剂量阿司匹林是否能预防健康老年人的疾病。这项研究最初获得了充足的资金，但将需要额外的支持，以完成数据收集和分析的关键最后阶段。这将使该研究能够回答有关阿司匹林在该年龄组的益处和风险及其对无残疾生存的影响的重要问题。